BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Marketing

Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla®

Global pharma major, Lupin Limited (Lupin) announced today that it has entered into a distribution agreement with Medis for Lupin’s orphan drug NaMus...

February 11, 2022 | News

Beijing Handian Pharamceutical Held an Expert Seminar About TCM Global Application In Beijing

he seminar first discussed the main reason causes the traditional Chinese medicine hardly used in other countries, which including the complex and rich eff...

January 27, 2022 | News

2022 Japan Prize Laureates Announced

In the field of Materials and ProductionProf. Katalin Kariko https://kyodonewsprwire.jp/img/202201075829-O3-9jI7uI4qProf. Drew Weissman ...

January 26, 2022 | News

Liminal BioSciences Announces Strategic Priorities for 2022

"2021 has been an important year for us: we have simplified our business strategy and created a liquidity reserve that will allow us to focus our resources...

January 24, 2022 | News

Bridget Johnson Joins CSafe Global as Senior Vice President of Marketing

CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, announced toda...

January 21, 2022 | News

Apex Medical Rebrands to Wellell, redefining core values

The rebranding in 2022 affirms the determination to establish a global foothold and further evolve the corporate organization, and to set even more ambitio...

January 14, 2022 | News

Pfizer Drives Cultural Change in Sustainable and Accessible Data with MicroStrategy

Understanding the importance of digital finance and data utility, Pfizer underwent a transformation and began to see data as an important corporate asset t...

January 11, 2022 | News

Viatris Wins Court Decisions on Sanofi Appeals of Lantus® Patent Invalidations

Viatris Inc. (NASDAQ: VTRS) announced that it is pleased with decisions issued today which affirm the U.S. Patent and Trademark Appeal Board's p...

December 30, 2021 | News

Novo Nordisk Announces Completion of Dicerna Pharmaceuticals Acquisition

Following the expiration of Novo Nordisk’s cash tender offer for Dicerna, Novo Nordisk has today acquired all outstanding shares of common stock of D...

December 29, 2021 | News

Japan Approves Molnupiravir for the Treatment of SARS-CoV-2 Infection

Japan’s Ministry of Health, Labor and Welfare Approves Molnupiravir for the Treatment of SARS-CoV-2 Infection Molnupiravir, First Oral COVID-19 Anti...

December 27, 2021 | News

Yiling Pharmaceutical's Patent Depression-resolving Drug Approved for Marketing in China

The drug is an innovative traditional Chinese medicine (TCM) independently developed by Yiling Pharmaceutical based on clinical practices, applicable to mi...

December 24, 2021 | News

Linepharma International Files for Manufacturing, Marketing Approval of the Abortion Pill in Japan

The medication is recognized as the international gold standard for first trimester medical abortioni and is on the World Health Organization (WH...

December 23, 2021 | News

BeiGene expands commercial portfolio in China

Strategic collaboration expected to advance clinical development of ociperlimab in combination with tislelizumab, including initiation and funding by Novar...

December 22, 2021 | News

EU Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine

Novavax and the European Commission previously announced an advance purchase agreement for up to 200 million doses through 2023 Authorization follows po...

December 21, 2021 | News

Stay Connected